SG11202010661SA - Oxo-substituted compound - Google Patents

Oxo-substituted compound

Info

Publication number: SG11202010661SA
Authority: SG; Singapore
Prior art keywords: oxo; substituted compound; substituted; compound
Prior art date: 2018-04-27

Application number

SG11202010661SA

Inventor

Toshio Kanai

Sachiko Koike

Takayuki Fukaya

Shunichiro UESUGI

Shingo Mizushima

Hitoshi Suda

Yuki Mizukami

Yohei Ikuma

Toshiaki Sunazuka

Yoshihiko Noguchi

Original Assignee

Sumitomo Dainippon Pharma Co Ltd

The Kitasato Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-04-27

Filing date

2019-04-26

Publication date

2020-11-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68295570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11202010661S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-04-26 Application filed by Sumitomo Dainippon Pharma Co Ltd, The Kitasato Inst filed Critical Sumitomo Dainippon Pharma Co Ltd

2020-11-27 Publication of SG11202010661SA publication Critical patent/SG11202010661SA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Virology (AREA)
Orthopedic Medicine & Surgery (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Cephalosporin Compounds (AREA)

SG11202010661SA 2018-04-27 2019-04-26 Oxo-substituted compound SG11202010661SA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2018087761		2018-04-27
PCT/JP2019/018011 WO2019208797A1 (en)	2018-04-27	2019-04-26	Oxo-substituted compound

Publications (1)

Publication Number	Publication Date
SG11202010661SA true SG11202010661SA (en)	2020-11-27

Family

ID=68295570

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11202010661SA SG11202010661SA (en)	2018-04-27	2019-04-26	Oxo-substituted compound

Country Status (13)

Country	Link
US (3)	US11702431B2 (en)
EP (1)	EP3786168A4 (en)
JP (2)	JP7360132B2 (en)
KR (1)	KR102679411B1 (en)
CN (2)	CN112135830B (en)
AU (1)	AU2019259818B2 (en)
CA (1)	CA3098433A1 (en)
EA (1)	EA202092579A1 (en)
MX (1)	MX2020011367A (en)
PH (1)	PH12020551772A1 (en)
SG (1)	SG11202010661SA (en)
TW (2)	TWI829686B (en)
WO (1)	WO2019208797A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW202038941A (en) *	2018-12-28	2020-11-01	日商大日本住友製藥股份有限公司	Alkyl-substituted compound
WO2021079984A1 (en) *	2019-10-25	2021-04-29	大日本住友製薬株式会社	Novel substituted condensed ring compound
US11476003B2 (en) *	2020-12-15	2022-10-18	Biodesix, Inc.	Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings
WO2024128238A1 (en) *	2022-12-13	2024-06-20	住友ファーマ株式会社	Therapeutic agent for bacterial infection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2878118T3 (en)	2012-12-07	2021-11-18	Venatorx Pharmaceuticals Inc	Beta-lactamase inhibitors
BR112015016002A2 (en)	2013-01-04	2017-07-11	Rempex Pharmaceuticals Inc	compounds, pharmaceutical compositions, chemical complexes and their uses and method for treating or preventing bacterial infection
CN104994844A (en)	2013-01-04	2015-10-21	莱姆派克斯制药公司	Boronic acid derivatives and therapeutic uses thereof
ES2730013T3 (en)	2013-01-10	2019-11-07	Venatorx Pharmaceuticals Inc	Betalactamase inhibitors
US9944658B2 (en)	2013-03-14	2018-04-17	VenatoRx Pharmaceuticals, Inc.	Beta-lactamase inhibitors
JP6672176B2 (en)	2014-05-19	2020-03-25	レンペックス・ファーマシューティカルズ・インコーポレイテッド	Boronic acid derivatives and their therapeutic use
WO2015191907A1 (en)	2014-06-11	2015-12-17	VenatoRx Pharmaceuticals, Inc.	Beta-lactamase inhibitors
JP6700203B2 (en)	2014-07-01	2020-05-27	レンペックス・ファーマシューティカルズ・インコーポレイテッド	Boronic acid derivatives and their therapeutic use
US20180051041A1 (en)	2015-03-17	2018-02-22	Rempex Pharmaceuticals, Inc.	Boronic acid derivatives and therapeutic uses thereof
CN108472284A (en)	2015-09-11	2018-08-31	维纳拓尔斯制药公司	Beta-lactamase inhibitor

2019
- 2019-04-26 KR KR1020207033733A patent/KR102679411B1/en active IP Right Grant
- 2019-04-26 TW TW108114791A patent/TWI829686B/en active
- 2019-04-26 MX MX2020011367A patent/MX2020011367A/en unknown
- 2019-04-26 TW TW113104603A patent/TW202421162A/en unknown
- 2019-04-26 CN CN201980028757.2A patent/CN112135830B/en active Active
- 2019-04-26 JP JP2020515615A patent/JP7360132B2/en active Active
- 2019-04-26 EP EP19793135.5A patent/EP3786168A4/en active Pending
- 2019-04-26 CA CA3098433A patent/CA3098433A1/en active Pending
- 2019-04-26 US US17/050,747 patent/US11702431B2/en active Active
- 2019-04-26 EA EA202092579A patent/EA202092579A1/en unknown
- 2019-04-26 CN CN202410723545.9A patent/CN118638140A/en active Pending
- 2019-04-26 SG SG11202010661SA patent/SG11202010661SA/en unknown
- 2019-04-26 AU AU2019259818A patent/AU2019259818B2/en active Active
- 2019-04-26 WO PCT/JP2019/018011 patent/WO2019208797A1/en active Application Filing
2020
- 2020-10-26 PH PH12020551772A patent/PH12020551772A1/en unknown
- 2020-12-29 US US17/136,806 patent/US11066425B1/en active Active
2023
- 2023-04-28 US US18/309,641 patent/US20230287009A1/en active Pending
- 2023-09-21 JP JP2023156567A patent/JP2023168413A/en active Pending

Also Published As

Publication number	Publication date
EP3786168A4 (en)	2022-03-23
EA202092579A1 (en)	2021-04-01
JP7360132B2 (en)	2023-10-12
MX2020011367A (en)	2021-02-09
TWI829686B (en)	2024-01-21
KR102679411B1 (en)	2024-07-01
CN112135830A (en)	2020-12-25
TW201945006A (en)	2019-12-01
KR20210005910A (en)	2021-01-15
BR112020021631A8 (en)	2023-02-28
CN118638140A (en)	2024-09-13
JPWO2019208797A1 (en)	2021-05-27
US11702431B2 (en)	2023-07-18
PH12020551772A1 (en)	2021-07-12
BR112020021631A2 (en)	2021-01-26
TW202421162A (en)	2024-06-01
US20230287009A1 (en)	2023-09-14
EP3786168A1 (en)	2021-03-03
AU2019259818A1 (en)	2020-11-26
JP2023168413A (en)	2023-11-24
CA3098433A1 (en)	2019-10-31
US11066425B1 (en)	2021-07-20
AU2019259818B2 (en)	2023-06-01
US20210147448A1 (en)	2021-05-20
WO2019208797A1 (en)	2019-10-31
CN112135830B (en)	2024-06-14

Publication	Publication Date	Title
PL3827042T3 (en)	2024-08-12	Multi-aziridine compound
GB201810092D0 (en)	2018-08-08	Compounds
GB201805174D0 (en)	2018-05-16	Compounds
GB201801355D0 (en)	2018-03-14	Compounds
GB201807924D0 (en)	2018-06-27	Compounds
GB201810581D0 (en)	2018-08-15	Compounds
ZA202101671B (en)	2022-07-27	Imidazopyridinone compound
SG11202010661SA (en)	2020-11-27	Oxo-substituted compound
GB201808093D0 (en)	2018-07-04	Compounds
GB201814151D0 (en)	2018-10-17	Compounds
GB201809102D0 (en)	2018-07-18	Compounds
SG11202012747VA (en)	2021-01-28	Compounds
GB201818649D0 (en)	2019-01-02	Compounds
GB201818651D0 (en)	2019-01-02	Compounds
GB201817083D0 (en)	2018-12-05	Compounds
GB201812382D0 (en)	2018-09-12	Compounds
GB201810071D0 (en)	2018-08-08	Compounds
GB201803340D0 (en)	2018-04-18	Compounds
GB201814167D0 (en)	2018-10-17	Compounds
GB201801130D0 (en)	2018-03-07	Compounds
GB201801128D0 (en)	2018-03-07	Compounds
GB201819102D0 (en)	2019-01-09	Compounds
GB201818927D0 (en)	2019-01-02	Compounds
GB201818698D0 (en)	2019-01-02	Compounds
GB201818410D0 (en)	2018-12-26	Compounds